Ham et al., 2014 - Google Patents
Peptidyl arginine deiminase-4 activation exacerbates kidney ischemia-reperfusion injuryHam et al., 2014
View PDF- Document ID
- 9390518258566872382
- Author
- Ham A
- Rabadi M
- Kim M
- Brown K
- Ma Z
- D'Agati V
- Lee H
- Publication year
- Publication venue
- American Journal of Physiology-Renal Physiology
External Links
Snippet
Peptidyl arginine deiminase (PAD) 4 is a nuclear enzyme that catalyzes the posttranslational conversion of arginine residues to citrulline. Posttranslational protein citrullination has been implicated in several inflammatory autoimmune diseases, including rheumatoid arthritis …
- 102100007049 PADI4 0 title abstract description 132
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ham et al. | Peptidyl arginine deiminase-4 activation exacerbates kidney ischemia-reperfusion injury | |
| Rabadi et al. | Peptidyl arginine deiminase-4-deficient mice are protected against kidney and liver injury after renal ischemia and reperfusion | |
| Günther et al. | Limitations and off-target effects of tryptophan-related IDO inhibitors in cancer treatment | |
| Knight et al. | Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice | |
| Raup-Konsavage et al. | Neutrophil peptidyl arginine deiminase-4 has a pivotal role in ischemia/reperfusion-induced acute kidney injury | |
| Beddowes et al. | Phase 1 dose-escalation study of pegylated arginine deiminase, cisplatin, and pemetrexed in patients with argininosuccinate synthetase 1–deficient thoracic cancers | |
| Valtorta et al. | Metformin and temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models | |
| You et al. | The tumor‐like phenotype of rheumatoid synovium: molecular profiling and prospects for precision medicine | |
| Huang et al. | PARP1-mediated PPARα poly (ADP-ribosyl) ation suppresses fatty acid oxidation in non-alcoholic fatty liver disease | |
| Que et al. | Frequent amplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1 blockade combination in soft tissue sarcoma | |
| Ebert et al. | Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus | |
| Klune et al. | HMGB1: endogenous danger signaling | |
| Sarkar et al. | Dual cancer-specific targeting strategy cures primary and distant breast carcinomas in nude mice | |
| Liu et al. | Nrf2 protection against liver injury produced by various hepatotoxicants | |
| Marsh et al. | Salvage therapy for refractory hemophagocytic lymphohistiocytosis: a review of the published experience | |
| Lu et al. | WDR5-H3K4me3 epigenetic axis regulates OPN expression to compensate PD-L1 function to promote pancreatic cancer immune escape | |
| Abdullah et al. | Activation of aryl hydrocarbon receptor signaling by a novel agonist ameliorates autoimmune encephalomyelitis | |
| Chan et al. | Belinostat and panobinostat (HDACI): in vitro and in vivo studies in thyroid cancer | |
| Choi et al. | Endothelial NF-κB blockade abrogates ANCA-induced GN | |
| Little et al. | Focus: skin: cutaneous lupus erythematosus: current and future pathogenesis-directed therapies | |
| Liu et al. | Targeting S1P1 receptor protects against murine immunological hepatic injury through myeloid-derived suppressor cells | |
| Costanza et al. | DNA threads released by activated CD4+ T lymphocytes provide autocrine costimulation | |
| Karmali et al. | Molecular subtyping in diffuse large B cell lymphoma: closer to an approach of precision therapy | |
| Engler et al. | SIRT6 regulates the cigarette smoke-induced signalling in rheumatoid arthritis synovial fibroblasts | |
| Rabadi et al. | ATP induces PAD4 in renal proximal tubule cells via P2X7 receptor activation to exacerbate ischemic AKI |